FI844775L - Sfingocinderivat, deras framstaellning och farmaceutiska produkt. - Google Patents

Sfingocinderivat, deras framstaellning och farmaceutiska produkt.

Info

Publication number
FI844775L
FI844775L FI844775A FI844775A FI844775L FI 844775 L FI844775 L FI 844775L FI 844775 A FI844775 A FI 844775A FI 844775 A FI844775 A FI 844775A FI 844775 L FI844775 L FI 844775L
Authority
FI
Finland
Prior art keywords
sfingocinderivat
farmaceutiska
produkt
deras framstaellning
framstaellning och
Prior art date
Application number
FI844775A
Other languages
English (en)
Other versions
FI844775A0 (fi
Inventor
Roland Tschannen
Wolfgang Fraefel
Richard Robert Schmidt
Rudolf Klaeger
Peter Zimmermann
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6493/83A external-priority patent/CH679209A5/de
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of FI844775A0 publication Critical patent/FI844775A0/fi
Publication of FI844775L publication Critical patent/FI844775L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI844775A 1983-12-05 1984-12-04 Sfingocinderivat, deras framstaellning och farmaceutiska produkt. FI844775L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6493/83A CH679209A5 (en) 1983-12-05 1983-12-05 New neutral glyco-sphingolipid derivs.
CH467184 1984-09-28

Publications (2)

Publication Number Publication Date
FI844775A0 FI844775A0 (fi) 1984-12-04
FI844775L true FI844775L (fi) 1985-06-06

Family

ID=25696036

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844775A FI844775L (fi) 1983-12-05 1984-12-04 Sfingocinderivat, deras framstaellning och farmaceutiska produkt.

Country Status (11)

Country Link
US (1) US4952683A (fi)
EP (1) EP0146810A3 (fi)
AU (1) AU570087B2 (fi)
CA (1) CA1259610A (fi)
DK (1) DK573384A (fi)
ES (2) ES8604986A1 (fi)
FI (1) FI844775L (fi)
HU (1) HU195516B (fi)
NO (1) NO844815L (fi)
PL (1) PL143901B1 (fi)
YU (2) YU202784A (fi)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
JPH07116209B2 (ja) * 1986-04-11 1995-12-13 メクト株式会社 シアロシルセラミド類及びその製造方法
EP0255717A3 (en) * 1986-08-06 1990-12-05 Mect Corporation Ganglioside related compounds and method of producing the same
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
ES2065343T3 (es) * 1987-06-26 1995-02-16 Solco Basel Ag Nuevos preparados farmaceuticos asi como nuevos compuestos de lactosilo y su preparacion.
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5066496A (en) * 1988-08-03 1991-11-19 Angio-Medical Corporation Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
DE3916072A1 (de) * 1989-05-17 1990-11-22 Thera Ges Fuer Patente Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese
DE4102817A1 (de) * 1991-01-31 1992-08-06 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von (beta)-fucopyranosyl-phosphaten und sehr reiner gdp-fucose
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (fi) * 1992-07-16 1995-11-01 Kirin Brewery
DE69328435T2 (de) * 1992-10-22 2000-09-14 Kirin Beer K.K., Tokio/Tokyo Neues sphingolglycolipid und verwendung davon
DE69416306T2 (de) * 1993-04-15 1999-06-17 Kirin Beer K.K., Tokio/Tokyo Sphingoglycolipid und verwendung davon
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
EP0754053A1 (en) * 1995-02-03 1997-01-22 Korea Institute of Science and Technology Novel hemostatic composition
ATE250139T1 (de) 1997-03-03 2003-10-15 Sumitomo Chemical Co Herstellung von einer optisch-aktiven sphingoid- verbindung
JP4553488B2 (ja) 1998-09-21 2010-09-29 大塚製薬株式会社 カルボキシメチルガラクトース誘導体
US20040180852A1 (en) * 2003-03-10 2004-09-16 Cara-Lynne Schengrund Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
WO2007112322A2 (en) * 2006-03-28 2007-10-04 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
US7794722B2 (en) 2006-06-30 2010-09-14 The Scripps Research Institute Adjuvants and methods of use
EP2125723A1 (en) 2007-01-11 2009-12-02 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
CN101918360A (zh) * 2007-09-24 2010-12-15 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
BRPI0918399A2 (pt) * 2008-08-12 2015-12-29 Allergan Inc composto antagonista do receptor de esfingosina-1-fosfato (s1p), bem como composição farmacêutica e uso do mesmo
US20120088800A1 (en) 2009-06-30 2012-04-12 Allergan, Inc. 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
US8168795B2 (en) * 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
JP2013506003A (ja) 2009-09-29 2013-02-21 アラーガン インコーポレイテッド スフィンゴシン−１−リン酸−２（ｓ１ｐ２）受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
KR20120098796A (ko) * 2009-11-24 2012-09-05 알러간, 인코포레이티드 치료적 유용성을 지니는 수용체 조절제로서의 신규한 화합물
JP2014503501A (ja) 2010-11-22 2014-02-13 アラーガン インコーポレイテッド 治療的有用性を伴う受容体調節因子としての新規化合物
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
SG10201804887YA (en) 2013-03-15 2018-07-30 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US20240132440A1 (en) 2021-01-25 2024-04-25 Carbocode S.A. Method for the production of d-erythro-sphingosine and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495548A (en) * 1974-04-16 1977-12-21 Tate & Lyle Ltd Sugar derivative containing vinyl groups and copolymers thereof
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals

Also Published As

Publication number Publication date
AU3628684A (en) 1985-06-13
US4952683A (en) 1990-08-28
FI844775A0 (fi) 1984-12-04
EP0146810A2 (de) 1985-07-03
YU189686A (en) 1987-12-31
DK573384D0 (da) 1984-12-03
CA1259610A (en) 1989-09-19
DK573384A (da) 1985-06-06
AU570087B2 (en) 1988-03-03
HU195516B (en) 1988-05-30
PL250710A1 (en) 1985-07-16
YU202784A (en) 1987-02-28
ES8606373A1 (es) 1986-04-16
ES548901A0 (es) 1986-04-16
HUT36833A (en) 1985-10-28
NO844815L (no) 1985-06-06
PL143901B1 (en) 1988-03-31
EP0146810A3 (de) 1987-05-13
ES8604986A1 (es) 1986-03-16
ES538231A0 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
FI844775A0 (fi) Sfingocinderivat, deras framstaellning och farmaceutiska produkt.
FI843594A0 (fi) Trihalogenmetylgrupper innehaollande karbonylmetylenheterocykler, foerfarande foer deras framstaellning och ljuskaenslig blandning vilken innehaoller dessa foereningar.
FI845038A0 (fi) Vattenloeslig, aminerad -1,3-bunden d-glukan och komposition innehaollande densamma.
FI77939B (fi) Askorbatstoerningsfri komposition, anordning och foerfarande foer bestaemning av peroxidativt aktiva substanser.
FI843403A0 (fi) Blandarmatur foer blandning av tvao vaetskor, saerskilt kallt och varmt vatten.
FI843856L (fi) 1-benzyl-aminoalkyl-pyrrolidinoner och deras syraadditionssalter, foerfarande foer deras framstaellning och laekemedel.
FI841128A0 (fi) Pyrimidinderivat, deras framstaellning och deras anvaendning.
FI842459A0 (fi) Tetrahydropyridazinonderivat, foerfaranden foer deras framstaellning och deras anvaendning.
FI843342A0 (fi) Anordning foer traening av benmuskulatur, cirkulation och armmuskulatur.
FI841841A0 (fi) 1-pyrimidinyloxi-3-hetarylalkylamino-2- propanoler, deras framstaellning och anvaendning.
FI844889L (fi) Foernaetade polymerater, foerfarande foer deras framstaellning och deras anvaendning.
FI840206A (fi) Aminosyraderivat, foerfarande foer deras framstaellning och anvaendning.
FI830032L (fi) Foerfarande och anordning foer bestaemmande av en oenskad centrallinje foer cylinderlika kroppar, saosom traestockar.
FI840428A (fi) Biologiskt aktivt ketonderivat, framstaellning och anvaendning.
FI842210A0 (fi) Kefalosporinester-derivat, deras framstaellning och anvaendning.
FI841615A0 (fi) 4-fenyl-tetrahydro-furano-pyridiner, foerfarande foer deras framstaellning och farmaceutiska blandningar.
FI841479A (fi) Fenylalaninhydroxilas- cdna- kloner, foerfarande foer framstaellning av dessa och anvaendning av dessa foer diagnostisering av fenylketonuri.
FI843825A0 (fi) Faergkatodstraolroer, komponent och framstaellningsmetod.
FI844002A0 (fi) Stabiliserade, inerta organiska vaetskor innehaollande natriumditionitprodukter och deras anvaendning.
FI840843A (fi) Plasmider, foerfarande foer framstaellning av dessa, mikroorganismer innehaollande dessa och foerfaranden foer odling av mikroorganismerna.
FI843824A0 (fi) Faergkatodstraolroer, komponent och framstaellningsmetod.
FI842300A0 (fi) Mono- och ditioestrar, deras framstaellning och anvaendning.
FI843973L (fi) Foerfarande foer oeverfoering, saerskilt foer registrering och aotergivning av faergtelevisionssignaler.
FI840587A (fi) Mjoeldryga-alkaloider, deras framstaellning och anvaendning.
FI833742A (fi) Adenokarcinomarelaterade antigendeterminanter och antikroppar specifika till dessa, foerfarande foer framstaellning daerav och daertillhoerande reagenssystem.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SOLCO BASEL AG